Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.1 TWD
170.21 M TWD
991.13 M TWD
20.44 M
About WeLeader Biomedical Co. Ltd.
Sector
Industry
CEO
Hung Jen Chen
Website
Headquarters
Kaohsiung City
Founded
2003
ISIN
TW0007713000
FIGI
BBG01KR7TJT5
WeLeader Biomedical Co. Ltd. engages in the production and sale of medical diagnostic equipment and materials. It provides serum biochemistry integration platform, clinical care and medical information integration systems. The company was founded on April 28, 2003 and is headquartered in Kaohsiung City, Taiwan.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 7713 is 73.9 TWD — it has increased by 1.09% in the past 24 hours. Watch WeLeader Biomedical Co. Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange WeLeader Biomedical Co. Ltd. stocks are traded under the ticker 7713.
7713 stock has risen by 1.79% compared to the previous week, the month change is a 3.21% rise, over the last year WeLeader Biomedical Co. Ltd. has showed a 3.65% increase.
7713 reached its all-time high on Dec 6, 2024 with the price of 86.0 TWD, and its all-time low was 54.2 TWD and was reached on Apr 7, 2025. View more price dynamics on 7713 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
7713 stock is 1.09% volatile and has beta coefficient of 0.76. Track WeLeader Biomedical Co. Ltd. stock price on the chart and check out the list of the most volatile stocks — is WeLeader Biomedical Co. Ltd. there?
Yes, you can track WeLeader Biomedical Co. Ltd. financials in yearly and quarterly reports right on TradingView.
WeLeader Biomedical Co. Ltd. is going to release the next earnings report on Nov 12, 2025. Keep track of upcoming events with our Earnings Calendar.
7713 net income for the last quarter is 50.01 M TWD, while the quarter before that showed 40.98 M TWD of net income which accounts for 22.04% change. Track more WeLeader Biomedical Co. Ltd. financial stats to get the full picture.
Yes, 7713 dividends are paid annually. The last dividend per share was 3.37 TWD. As of today, Dividend Yield (TTM)% is 4.56%. Tracking WeLeader Biomedical Co. Ltd. dividends might help you take more informed decisions.
As of Sep 29, 2025, the company has 209 employees. See our rating of the largest employees — is WeLeader Biomedical Co. Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WeLeader Biomedical Co. Ltd. EBITDA is 333.57 M TWD, and current EBITDA margin is 32.42%. See more stats in WeLeader Biomedical Co. Ltd. financial statements.
Like other stocks, 7713 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WeLeader Biomedical Co. Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WeLeader Biomedical Co. Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WeLeader Biomedical Co. Ltd. stock shows the buy signal. See more of WeLeader Biomedical Co. Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.